Royal Bank of Canada
COCP icon

Royal Bank of Canada’s Cocrystal Pharma COCP Stock Holding History

Royal Bank of Canada’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
51
– – ﹤0.01% 7196
2025
Q4 		$0 Hold
51
– – ﹤0.01% 7225
2025
Q3 		$0 Hold
51
– – ﹤0.01% 7178
2025
Q2 		$0 Hold
51
– – ﹤0.01% 7065
2025
Q1 		$0 Hold
51
– – ﹤0.01% 6867
2024
Q4 		$0 Hold
51
– – ﹤0.01% 6931
2024
Q3 		$0 Hold
51
– – ﹤0.01% 6926
2024
Q2 		$0 Hold
51
– – ﹤0.01% 7109
2024
Q1 		$0 Buy
51
+42
+467% +$65 ﹤0.01% 7075
2023
Q4 		$0 Hold
9
– – ﹤0.01% 7173
2023
Q3 		$0 Hold
9
– – ﹤0.01% 7140
2023
Q2 		$0 Hold
9
– – ﹤0.01% 7306
2023
Q1 		$0 Hold
9
– – ﹤0.01% 7120
2022
Q4 		$0 Buy
9
+1
+13% +$3 ﹤0.01% 7284
2022
Q3 		$0 Hold
8
– – ﹤0.01% 7491
2022
Q2 		$0 Buy
+8
New +$43 ﹤0.01% 7406
2020
Q3 		– Sell
-93
Closed -$2K – 6659
2020
Q2 		$2K Sell
93
-14,771
-99% -$181K ﹤0.01% 6272
2020
Q1 		$126K Buy
14,864
+14,853
+135,027% +$140K ﹤0.01% 4626
2019
Q4 		$0 Sell
11
-59,453
-100% -$594K ﹤0.01% 6851
2019
Q3 		$1.46M Buy
59,464
+27
+0% +$700 ﹤0.01% 3013
2019
Q2 		$1.68M Hold
59,437
– – ﹤0.01% 2897
2019
Q1 		$1.95M Buy
59,437
+59,270
+35,491% +$2.17M ﹤0.01% 2706
2018
Q4 		$7K Hold
167
– – ﹤0.01% 6025
2018
Q3 		$5K Hold
167
– – ﹤0.01% 6249
2018
Q2 		$7K Sell
167
-166
-50% -$6.16K ﹤0.01% 5924
2018
Q1 		$24K Buy
+333
New +$20.8K ﹤0.01% 5384

Other funds holding COCP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Royal Bank of Canada's COCP Position: Q1 2026 in Review

Royal Bank of Canada held its Cocrystal Pharma (COCP) position steady in Q1 2026 at 51 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7196.

Royal Bank of Canada first reported a position in COCP in Q1 2018 and has held it in 26 quarters since. The position peaked at $1.95M in Q1 2019. 26 funds tracked by Wall St. Rank hold COCP as of Q1 2026.

  • Royal Bank of Canada held 51 shares of Cocrystal Pharma worth $0 as of Q1 2026.
  • Royal Bank of Canada left its Cocrystal Pharma share count unchanged in Q1 2026.
  • Cocrystal Pharma made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7196 holding.
  • Royal Bank of Canada first reported a position in Cocrystal Pharma in Q1 2018 and has held it in 26 quarters since.
  • Royal Bank of Canada's Cocrystal Pharma position peaked at $1.95M in Q1 2019.
  • 26 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.